Trials / Conditions / Cholangiocarcinoma, Intrahepatic

Cholangiocarcinoma, Intrahepatic

20 registered clinical trials studyying Cholangiocarcinoma, Intrahepatic — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary T NCT07454486	Aarhus University Hospital	—
Recruiting	Liver Transplantation in Intrahepatic Cholangiocarcinoma NCT06140134	Rutgers, The State University of New Jersey	—
Completed	Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC) NCT06381648	City of Hope Medical Center	—
Unknown	Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma NCT05124002	Beijing Tsinghua Chang Gung Hospital	Phase 4
Active Not Recruiting	Percutaneous Cholangiopancreatoscopy Registry NCT05210322	Johns Hopkins University	—
Active Not Recruiting	PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Pr NCT04634058	Shanghai Zhongshan Hospital	Phase 2
Unknown	Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Re NCT04782804	Fudan University	Phase 1 / Phase 2
Unknown	Cisplatin and Gemcitabine Chemotherapy and Lenvatinib for Patients With Unresectable Intrahepatic Cholangiocar NCT04527679	Shanghai Zhongshan Hospital	Phase 2
Unknown	PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangioca NCT04506281	Shanghai Zhongshan Hospital	Phase 2
Completed	Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinom NCT04361331	Shanghai Zhongshan Hospital	Phase 2
Completed	Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative NCT04264260	Kaohsiung Medical University Chung-Ho Memorial Hospital	Phase 2
Enrolling By Invitation	Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma NCT04195503	University Health Network, Toronto	N/A
Unknown	Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic Cholang NCT04077983	Shanghai Zhongshan Hospital	Phase 2
Unknown	Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patie NCT03951597	Shanghai Zhongshan Hospital	Phase 2
Completed	Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study NCT03405909	University Hospital Erlangen	—
Terminated	Study of GNS561 in Patients With Liver Cancer NCT03316222	Genoscience Pharma	Phase 1 / Phase 2
Completed	A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma NCT03377179	RedHill Biopharma Limited	Phase 2
Terminated	Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; NCT03267940	Halozyme Therapeutics	Phase 1
Completed	Surgery for Recurrent Intrahepatic Cholangiocarcinoma NCT04072250	Chang Gung Memorial Hospital	—
No Longer Available	Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®) NCT03414489	RedHill Biopharma Limited	—